FWIW - i generally agree, since, as I've noted multiple times, unless the sham has a strong effect on breaking blind and thus causing very misleading efficacy… its not within FDA’s mandate to *force* a no sham policy. And… the previous OCUL management were pretty naive about all of this.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.